title: A novel thyroid transcription factor is essential for thyrotropin-induced up-regulation of Na+/I- symporter gene expression.
abstract: The stimulation of iodide (I-) transport by TSH in FRTL-5 thyroid cells is partly due to an increase in Na+/I- symporter (NIS) gene expression. The identification of a TSH-responsive element (TRE) in the NIS promoter and its relationship to the action of thyroid transcription factor-1 (TTF-1) on the promoter are the subjects of this report. By transfecting NIS promoter-luciferase chimeric plasmids into FRTL-5 cells in the presence or absence of TSH, we identify a TRE between -420 and -370 bp of the NIS 5'-flanking region. Nuclear extracts from FRTL-5 cells cultured in the absence of TSH form two groups of protein-DNA complexes, A and B, in gel mobility shift assays using an oligonucleotide having the sequence from -420 to -385 bp. Only the A complex is increased by exposure of FRTL-5 cells to TSH or forskolin. The addition of TSH to FRTL-5 cells can increase the A complex at 3-6 h, reaching a maximum at 12 h. FRTL-5, but not nonfunctioning FRT thyroid or Buffalo rat liver (BRL) cell nuclear extracts, form the A complex. The TSH-increased nuclear factor in FRTL-5 cells interacting with the NIS TRE is distinct from TTF-1, thyroid transcription factor-2, or Pax-8, as evidenced by the absence of competition using oligonucleotides specific for these factors in gel shift assays. Neither is it the nuclear protein interacting with cAMP response element. The TRE is in the upstream of a TTF-1-binding site, -245 to -230 bp. Mutation of the TRE causing a loss of TSH responsiveness also decreases TTF-1-induced promoter activity in a transfection experiment. The formation of the A complex between FRTL-5 nuclear extracts and the NIS TRE is redox-regulated. In sum, TSH/cAMP-induced up-regulation of the NIS requires a novel thyroid transcription factor, which also appears to be involved in TTF-1-mediated thyroid-specific NIS gene expression.
authors.affiliation: Third Department of Internal Medicine, Yamanashi Medical University, Tamaho, Japan.
authors.forename: M
authors.initials: M
authors.lastname: Ohmori
authors.forename: T
authors.initials: T
authors.lastname: Endo
authors.forename: N
authors.initials: N
authors.lastname: Harii
authors.forename: T
authors.initials: T
authors.lastname: Onaya
mesh_terms: D000818:Animals; D002352:Carrier Proteins / Q000187:drug effects / Q000235:genetics*; D002460:Cell Line; D019175:DNA Methylation; D004252:DNA Mutational Analysis; D004268:DNA-Binding Proteins / Q000235:genetics; D051858:Forkhead Transcription Factors; D005786:Gene Expression Regulation / Q000187:drug effects; D007455:Iodine / Q000502:physiology; D008565:Membrane Proteins / Q000187:drug effects / Q000235:genetics*; D009687:Nuclear Proteins / Q000235:genetics / Q000502:physiology*; D010084:Oxidation-Reduction; D000072636:PAX8 Transcription Factor; D051761:Paired Box Transcription Factors; D011401:Promoter Regions, Genetic / Q000187:drug effects / Q000235:genetics; D051381:Rats; D011915:Rats, Inbred BUF; D012097:Repressor Proteins / Q000235:genetics; D027981:Symporters; D013961:Thyroid Gland / Q000166:cytology / Q000502:physiology*; D000074482:Thyroid Nuclear Factor 1; D013972:Thyrotropin / Q000494:pharmacology*; D015534:Trans-Activators / Q000235:genetics; D014157:Transcription Factors / Q000235:genetics / Q000502:physiology*; D015854:Up-Regulation / Q000187:drug effects / Q000235:genetics*; D000099209:Sodium-Iodide Symporters
chemical_list: D002352:Carrier Proteins; D004268:DNA-Binding Proteins; D051858:Forkhead Transcription Factors; D007455:Iodine; D008565:Membrane Proteins; D009687:Nuclear Proteins; D000072636:PAX8 Transcription Factor; D051761:Paired Box Transcription Factors; D012097:Repressor Proteins; D027981:Symporters; D000074482:Thyroid Nuclear Factor 1; D013972:Thyrotropin; D015534:Trans-Activators; D014157:Transcription Factors; D000099209:Sodium-Iodide Symporters; C106894:FOXE1 protein, human; C000614412:NKX2-1 protein, human; C000614416:Nkx2-1 protein, rat; C499497:Pax8 protein, rat